Cresemba (isavuconazonium sulfate) - Astellas, Basilea
Mucormycosis outbreak caused by Rhizomucor pusillus in a Hematopoietic Stem Cell Transplant Unit, Brazil. (PubMed, Med Mycol) - Oct 2, 2026 - "Survivors (75%) received treatment with lipid complex amphotericin B, isavuconazole, and/or surgical resection...We characterize the first reported outbreak investigation of mucormycosis caused by R. pusillus in a brazilian HSCT unit, with favorable outcome in most cases despite aggressive clinical presentation. Despite the lack of clonality and negative environmental investigation, epidemiological evidence strongly suggests nosocomial transmission." 
Journal • Bone Marrow Transplantation • Infectious Disease • Respiratory Diseases • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42820723
 
Bram Spruijtenburg; Eelco F J Meijer; Flávio Queiroz-Telles; Giovanni Luís Breda; Gisele Loth; Graziela Cristina Buzutti Canova; Rafaella Muratori; Regielly Caroline Raimundo Cognialli; Samir Kanaan Nabhan; Vaneuza Araújo Moreira Funke; Vania Aparecida Vicente
 
Oct 2, 2026
 
Prev Next